APG Asset Management US’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
APG Asset Management US's MRNA Position: Q1 2025 in Review
APG Asset Management US sold out of Moderna (MRNA) in Q1 2025, closing a stake of 6,752 shares — an estimated $281K sold.
APG Asset Management US first reported a position in MRNA in Q4 2023 and held it in 5 quarters. The position peaked at $6.23M in Q4 2023. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.
- APG Asset Management US reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
- APG Asset Management US sold 6,752 Moderna shares in Q1 2025, an estimated $281K.
- APG Asset Management US first reported a position in Moderna in Q4 2023 and held it in 5 quarters.
- APG Asset Management US's Moderna position peaked at $6.23M in Q4 2023.
- 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.
Based on APG Asset Management US's 13F filing for Q1 2025, filed 14 May 2025.